Chunghwa Chemical Synthesis & Biotech Co., Ltd. Price (1762.TW)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

78,092,000

(0.5197)%

Chunghwa Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineop... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $32.5-53.7
  • Market Cap 2.56B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Mr. Chung-Hsin Huang
  • IPO Date: December, 20, 2010
  • Country: TW
  • Currency: TWD
  • Headquaters: No Data
  • Employees: 243

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation